Inventor · disambiguated record
Duanjie Hou
Also filed as: HOU DUANJIE
18 granted patents·8 pending applications·305 citations·filing 2001–2018
94Inventor score
Top patents by PatentIndex Score
26 records- 0195US8466188B2Use of spiro-oxindole compounds as therapeutic agentsCHAFEEV MIKHAIL·Filed 2007·Granted Jun 18, 2013·63 cites·1 claims
- 0295US7700641B2Spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·39 cites·41 claims
- 0393US7767677B2Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Aug 3, 2010·34 cites·10 claims
- 0492US7592343B2Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Sep 22, 2009·22 cites·6 claims
- 0592US7335658B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Feb 26, 2008·59 cites·95 claims
- 0691US8106087B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 31, 2012·19 cites·6 claims
- 0791US7547698B2Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)XENON PHARMACEUTICALS INC·Filed 2005·Granted Jun 16, 2009·18 cites·9 claims
- 0886US8541457B2Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitorsFU JIANMIN·Filed 2006·Granted Sep 24, 2013·16 cites·4 claims
- 0985US8049016B2Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymesNOVARTIS AG·Filed 2009·Granted Nov 1, 2011·7 cites·19 claims
- 1085US7919484B2Combination therapyXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 5, 2011·10 cites·18 claims
- 1181US8071603B2Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitorsKAMBOJ RAJENDER·Filed 2005·Granted Dec 6, 2011·10 cites·5 claims
- 1278US8501746B2Organic compoundsDALES NATALIE·Filed 2007·Granted Aug 6, 2013·3 cites·16 claims
- 1378US8026360B2Substituted pyridazines as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2009·Granted Sep 27, 2011·3 cites·5 claims
- 1475US7754711B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·2 cites·6 claims
- 1564US9187426B2Organic compoundsDALES NATALIE·Filed 2009·Granted Nov 17, 2015·0 cites·2 claims
- 1660US2011009414A9Heterocyclic derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1753US2012122909A9Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2011·Application pending·0 cites
- 1851US2014024583A1Organic compoundsNOVARTIS AG·Filed 2013·Application pending·0 cites
- 1946US8318949B2Organic compoundsCHOWDHURY SULTAN·Filed 2011·Granted Nov 27, 2012·0 cites·11 claims
- 2045US2013096056A1Aminothiazole derivatives as human stearoyl-coa desaturase inhibitorsFU JIANMIN·Filed 2012·Application pending·0 cites
- 2143US7951805B2Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturaseXENON PHARMACEUTICALS INC·Filed 2005·Granted May 31, 2011·0 cites·16 claims
- 2243US2007105820A1Oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2342US2016289191A1Organic compoundsDALES NATALIE·Filed 2015·Application pending·0 cites
- 2441US11384062B2Deuterated (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamideCOMBIPHOS CATALYSTS INC·Filed 2018·Granted Jul 12, 2022·0 cites·19 claims
- 2540US2003232797A1Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disordersFORBES MEDI TECH INC·Filed 2002·Application pending·0 cites
- 2639US2002156051A1Novel structures comprising phytosterol and/or phytostanol and ascorbic acid and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disordersFORBES MEDI TECH INC·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Duanjie Hou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →